JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Published by SAGE
ISSN : 1470-3203 eISSN : 1752-8976
Abbreviation : JRAAS J. Renin-angiotensin-aldosterone Syst.
Aims & Scope
Journal of the Renin Angiotensin Aldosterone System is a peer-reviewed, open access journal published quarterly as a resource for biomedical professionals, including basic scientists and clinicians, primarily with an active interest in the renin-angiotensin-aldosterone system in humans and other mammals.
It publishes original research articles and reviews on the normal and abnormal function of this system and its pharmacology and therapeutics, mostly in a cardiovascular context but including research in all areas where this system is present, including the brain, lungs, and gastro-intestinal tract.
Although this is its main focus, JRAAS also publishes research on other peptides, such as vasopressin, the natriuretic peptides and the kallikrein-kinin system.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 4.1 |
2024 | 2.10 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.750 |
Quartile
Year | Value |
---|---|
2024 | Q2 |
h-index
Year | Value |
---|---|
2024 | 52 |
Journal Rank
Year | Value |
---|---|
2024 | 7403 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 182 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression
Citation: 231
Authors: Raymond, Michael Anthonius, Ian, Sunu Budhi, Antonia Anna
-
The Pickering Lecture British Hypertension Society, 10th September 2002
Citation: 173
Authors: David G, Ulf, Kathy K
-
Role of Angiotensin II in Cardiovascular Disease — Therapeutic Implications of More Than a Century of Research
Citation: 170
Authors: Carlos M
-
Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension
Citation: 159
Authors: Yagiz, Addison A, Charles, Diethelm, Massimo, Ghionul, Andrew
-
The angiotensin II type 2 receptor in cardiovascular disease
Citation: 134
Authors: Catherine A, Ernesto L
-
Review: Diagnosis and management of primary aldosteronism
Citation: 119
Authors: Michael, Richard D, John C, Nik Z, Nicholas, Gregory J
-
The renin-angiotensin system meets the hallmarks of cancer
Citation: 114
Authors: Talia, Ernesto, Silvia, José
-
Review: Angiotensin II type 1 receptor blockers: class effects versus molecular effects
Citation: 109
Authors: Shin-ichiro, Sadashiva S., Keijiro